Granahan Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-43,414	Closed	-$3.09M	–	180
2022 Q1	$3.09M	Sell	43,414 -141,997	-77%	-$9.24M	0.08%	155
2021 Q4	$13.9M	Buy	185,411 +2,595	+1%	+$204K	0.29%	97
2021 Q3	$10.4M	Sell	182,816 -17,154	-9%	-$848K	0.2%	109
2021 Q2	$8.8M	Buy	199,970 +6,554	+3%	+$321K	0.16%	120
2021 Q1	$9.54M	Sell	193,416 -37,655	-16%	-$1.88M	0.2%	95
2020 Q4	$9.73M	Buy	231,071 +42,907	+23%	+$1.89M	0.22%	94
2020 Q3	$8.61M	Sell	188,164 -17,236	-8%	-$835K	0.29%	83
2020 Q2	$10.3M	Buy	205,400 +56,800	+38%	+$2.94M	0.37%	76
2020 Q1	$7.64M	Sell	148,600 -693	-0.5%	-$36.9K	0.41%	64
2019 Q4	$9.22M	Buy	149,293 +689	+0.5%	+$42.7K	0.42%	68
2019 Q3	$8.93M	Buy	148,604 +4,805	+3%	+$357K	0.49%	62
2019 Q2	$12.1M	Sell	143,799 -7,523	-5%	-$677K	0.6%	47
2019 Q1	$14.5M	Sell	151,322 -685	-0.5%	-$61.4K	0.78%	41
2018 Q4	$10.8M	Buy	152,007 +48,687	+47%	+$3.73M	0.76%	45
2018 Q3	$8.83M	Buy	103,320 +2,650	+3%	+$265K	0.48%	68
2018 Q2	$11.7M	Buy	100,670 +7,763	+8%	+$775K	0.7%	44
2018 Q1	$7.52M	Buy	92,907 +3,096	+3%	+$238K	0.54%	60
2017 Q4	$5.27M	Sell	89,811 -12,230	-12%	-$612K	0.41%	86
2017 Q3	$4.78M	Sell	102,041 -49,654	-33%	-$2M	0.4%	91
2017 Q2	$5.46M	Sell	151,695 -45,713	-23%	-$1.46M	0.5%	75
2017 Q1	$6.08M	Sell	197,408 -298,617	-60%	-$9.3M	0.61%	58
2016 Q4	$16.6M	Buy	496,025 +24,890	+5%	+$713K	0.57%	71
2016 Q3	$12.5M	Buy	471,135 +57,720	+14%	+$1.34M	0.41%	104
2016 Q2	$9.12M	Sell	413,415 -3,010	-0.7%	-$78.8K	0.33%	114
2016 Q1	$12.2M	Buy	416,425 +63,400	+18%	+$1.77M	0.44%	81
2015 Q4	$11.7M	Sell	353,025 -50,405	-12%	-$1.64M	0.4%	93
2015 Q3	$14.6M	Buy	403,430 +168,300	+72%	+$7.23M	0.45%	79
2015 Q2	$10.6M	Buy	+235,130	New	+$9.15M	0.3%	120